Moleculin Biotech, INC. (MBRX) SEC Filings — 2025
49 SEC filings for Moleculin Biotech, INC. (MBRX) in 2025.
Filings
- Moleculin Biotech Enters Material Definitive Agreement — 8-K · Dec 22, 2025
- Moleculin Biotech Files 8-K — 8-K · Dec 17, 2025
- Moleculin Biotech Files 8-K — 8-K · Dec 16, 2025
- Moleculin Biotech Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 10, 2025
- Moleculin Biotech, INC. 8-K Filing — 8-K · Dec 9, 2025
- Moleculin Biotech, INC. 8-K Filing — 8-K · Dec 8, 2025
- Moleculin Biotech, INC. 8-K Filing — 8-K · Nov 28, 2025
- Moleculin Biotech Files 8-K — 8-K · Nov 24, 2025
- Moleculin Biotech, INC. 8-K Filing — 8-K · Nov 21, 2025
- Moleculin Biotech's Net Loss Widens to $49.1M Amid Warrant Issuances — 10-Q · Nov 13, 2025
- Moleculin Biotech, INC. 8-K Filing — 8-K · Nov 12, 2025
- Moleculin Biotech Files 8-K with Corporate Updates — 8-K · Oct 30, 2025
- Moleculin Biotech Files 8-K Report — 8-K · Oct 29, 2025
- Moleculin Biotech Files 8-K — 8-K · Oct 23, 2025
- Moleculin Biotech Files 8-K on Security Holder Vote — 8-K · Oct 16, 2025
- Moleculin Biotech Files 8-K Report — 8-K · Sep 25, 2025
- Moleculin Seeks Shareholder Nod for 64.8M Warrant Issuance, Name Change — DEF 14A · Sep 15, 2025
- Moleculin Biotech Files 8-K with Exhibits — 8-K · Sep 9, 2025
- Moleculin Biotech Files 8-K with Corporate Updates — 8-K · Sep 8, 2025
- Moleculin Biotech Files 8-K: Material Agreement & Equity Sales — 8-K · Aug 29, 2025
- Moleculin Biotech Files 8-K with Corporate Updates — 8-K · Aug 27, 2025
- Moleculin Biotech Files 8-K on Shareholder Votes — 8-K · Aug 18, 2025
- Moleculin Biotech Files 8-K on Financials — 8-K · Aug 13, 2025
- Moleculin Biotech Burns Cash, Raises Capital Amidst Zero Revenue — 10-Q · Aug 12, 2025
- Moleculin Biotech Files 8-K with Financials and Disclosures — 8-K · Aug 6, 2025
- Moleculin Biotech Files 8-K Current Report — 8-K · Aug 1, 2025
- Moleculin Biotech Files 8-K — 8-K · Jul 30, 2025
- Moleculin Biotech Files 8-K with Corporate Updates — 8-K · Jul 17, 2025
- Moleculin Biotech Files 8-K: Material Agreement & Exhibits — 8-K · Jul 11, 2025
- Moleculin Biotech Files 8-K Report — 8-K · Jul 9, 2025
- Moleculin Biotech Details Executive Equity Awards 2021-2024 — DEF 14A · Jul 8, 2025
- Moleculin Biotech Faces Delisting Concerns — 8-K · Jun 27, 2025
- Moleculin Biotech Files 8-K: Material Agreement & Financials — 8-K · Jun 23, 2025
- Moleculin Biotech Files 8-K: Financials & Other Events — 8-K · Jun 18, 2025
- Moleculin Biotech Files S-1/A for Continuous Offering — S-1/A · Jun 16, 2025
- Moleculin Biotech Files S-1/A for Continuous Offering — S-1/A · Jun 11, 2025
- Moleculin Biotech Amends S-1, Signals Future Capital Raise — S-1/A · Jun 6, 2025
- Moleculin Biotech Files 8-K with Financials — 8-K · Jun 5, 2025
- Moleculin Biotech Files 8-K — 8-K · Jun 4, 2025
- Moleculin Biotech Files S-1 for Continuous Offering — S-1 · Jun 2, 2025
- Moleculin Biotech Faces Delisting Concerns — 8-K · May 23, 2025
- Moleculin Biotech Files 8-K on Operations and Financials — 8-K · May 14, 2025
- Moleculin Biotech Q1 2025: Cash Burn Continues — 10-Q · May 13, 2025
- Moleculin Biotech Files 8-K — 8-K · May 12, 2025
- Moleculin Biotech Files 8-K on Shareholder Votes — 8-K · May 9, 2025
- Moleculin Biotech Files 8-K — 8-K · May 7, 2025
- Moleculin Biotech Files 8-K — 8-K · May 6, 2025
- Moleculin Biotech Files 8-K with Corporate Updates — 8-K · May 5, 2025
- Moleculin Biotech Files 2024 10-K Amendment — 10-K/A · Apr 30, 2025